Last reviewed · How we verify

NCT05840172

A Clinical Investigation to Assess the Effectiveness of Benzocaine in NRL Condoms in Healthy Adult Men Who Feel They Ejaculate Too Quickly During Vaginal Sex

Completed NA Last updated 14 July 2025
What this trial tests

NA trial testing Test condom A (NRL condom with 5% benzocaine paste) in Ejaculation Delayed in 300 participants. Completed in 7 October 2024.

Timeline
19 October 2023
Primary endpoint
7 October 2024
7 October 2024

Quick facts

Lead sponsorReckitt Benckiser Healthcare (UK) Limited
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeother
Enrollment300
Start date19 October 2023
Primary completion7 October 2024
Estimated completion7 October 2024
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Reckitt Benckiser Healthcare (UK) Limited — full company profile →

Who can join

Adults 18 to 60, any sex, with Ejaculation Delayed. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigation is to evaluate the effectiveness of benzocaine in two NRL condoms compared with a standard NRL control without benzocaine in prolonging time to ejaculation in healthy adult men who feel they ejaculate too quickly during vaginal sex.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Reckitt Benckiser Healthcare (UK) Limited trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05840172.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing